Corrigendum to "Gene expression profiling of human lymph node metastases and matched primary breast carcinomas: Clinical implications" [Mol. Oncol. 1 (2007) 172-180] (DOI:10.1016/j.molonc.2007.03.005);Gene expression profiling of human lymph node metastases and matched primary breast carcinomas: Clinical implications

Molecular Oncology

Volumn 1, Issue 2, 2007, Pages 172-180

  Suzuki, Mika ^a   Tarin, David ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Breast cancer; Clonal heterogeneity; Gene expression; Metastasis; Tumor progression

Indexed keywords

ARTICLE; BREAST CARCINOMA; CONCEPTUAL FRAMEWORK; CONTROLLED STUDY; DNA MICROARRAY; GENE EXPRESSION PROFILING; GENETIC CODE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LYMPH NODE METASTASIS; MATHEMATICAL ANALYSIS; MOLECULAR BIOLOGY; MOLECULAR DYNAMICS; MOLECULAR PROBE; NUCLEOTIDE SEQUENCE; PATHOGENESIS; PRIORITY JOURNAL; PROGNOSIS; VALIDATION PROCESS;

EID: 34547569120     PISSN: 15747891     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.molonc.2007.11.001     Document Type: Erratum

References (34)

1. Baban D., Matsumura Y., Kocialkowski S., and Tarin D. Studies on relationships between metastatic and non-metastatic tumor cell populations using lineages labeled with dominant selectable genetic markers. Int. J. Dev. Biol. 37 1 (1993) 237-243
2. Bao L., Pigott R., Matsumura Y., Baban D., and Tarin D. Correlation of VLA-4 integrin expression with metastatic potential in various human tumour cell lines. Differentiation 52 3 (1993) 239-246
3. Bernards R., and Weinberg R.A. A progression puzzle. Nature 418 6900 (2002) 823
4. Bloom H.J., and Richardson W.W. Histological grading and prognosis in breast cancer: a study of 1409 cases of which 359 have been followed for 15 years. Br. J. Cancer 11 3 (1957) 359-377
5. Feng Y., Sun B., Li X., et al. Differentially expressed genes between primary cancer and paired lymph node metastases predict clinical outcome of node-positive breast cancer patients. Breast Cancer Res. Treat (2006). Available from: www.springerlink.com 10.1007/s10549-006-9385-7 (PMID number 17123152)
6. Fidler I.J., and Kripke M.L. Metastasis results from preexisting variant cells within a malignant tumor. Science 197 4306 (1977) 893-895
7. Hampton T. Breast cancer gene chip study under way: can new technology help predict treatment success?. JAMA 291 24 (2004) 2927-2930
8. Hao X., Sun B., Hu L., et al. Differential gene and protein expression in primary breast malignancies and their lymph node metastases as revealed by combined cDNA microarray and tissue microarray analysis. Cancer 100 6 (2004) 1110-1122
9. Jenssen T.K., and Hovig E. Gene-expression profiling in breast cancer. Lancet 365 9460 (2005) 634-635
10. Kallioniemi O. Medicine: profile of a tumour. Nature 428 6981 (2004) 379-382
11. Kripke M.L., Gruys E., and Fidler I.J. Metastatic heterogeneity of cells from an ultraviolet light-induced murine fibrosarcoma of recent origin. Cancer Res. 38 9 (1978) 2962-2967
12. Lahdesmaki H., Hao X., Sun B., et al. Distinguishing key biological pathways between primary breast cancers and their lymph node metastases by gene function-based clustering analysis. Int. J. Oncol. 24 6 (2004) 1589-1596
13. Li C., and Wong W.H. Model-based analysis of oligonucleotide arrays: expression index computation and outlier detection. Proc. Natl. Acad. Sci. USA 98 1 (2001) 31-36
14. Li C., and Wong W.H. Model-based analysis of oligonucleotide arrays: model validation, design issues and standard error application. Genome Biol. 2 (2001) (RESEARCH 0032, Epub)
15. Moffett B.F., Baban D., Bao L., and Tarin D. Fate of clonal lineages during neoplasia and metastasis studied with an incorporated genetic marker. Cancer Res. 52 7 (1992) 1737-1743
16. Montel V., Pestonjamasp K., Mose E., and Tarin D. Tumor-host interactions contribute to the elevated expression level of alpha1-antichymotrypsin in metastatic breast tumor xenografts. Differentiation 73 2-3 (2005) 88-98
17. Montel V., Huang T.Y., Mose E., Pestonjamasp K., and Tarin D. Expression profiling of primary tumors and matched lymphatic and lung metastases in a xenogeneic breast cancer model. Am. J. Pathol. 166 5 (2005) 1565-1579
18. Montel V., Kleeman J., Agarwal D., Spinella D., Kawai K., and Tarin D. Altered metastatic behavior of human breast cancer cells after experimental manipulation of matrix metalloproteinase 8 gene expression. Cancer Res. 64 5 (2004) 1687-1694
19. Montel V., Mose E.S., and Tarin D. Tumor-stromal interactions reciprocally modulate gene expression patterns during carcinogenesis and metastasis. Int. J. Cancer 119 (2006) 251-263
20. Nicolson G.L., Brunson K.W., and Fidler I.J. Specificity of arrest, survival, and growth of selected metastatic variant cell lines. Cancer Res. 38 11 Pt 2 (1978) 4105-4111
21. Paget S. The distribution of secondary growths in cancer of the breast. Lancet 1 (1889) 571-573
22. Poste G., Doll J., and Fidler I.J. Interactions among clonal subpopulations affect stability of the metastatic phenotype in polyclonal populations of B16 melanoma cells. Proc. Natl. Acad. Sci. USA 78 10 (1981) 6226-6230
23. Ramaswamy S., Ross K.N., Lander E.S., and Golub T.R. A molecular signature of metastasis in primary solid tumors. Nat. Genet. 33 1 (2003) 49-54
24. Stuart R.O., Wachsman W., Berry C.C., et al. In silico dissection of cell-type-associated patterns of gene expression in prostate cancer. Proc. Natl. Acad. Sci. USA 101 2 (2004) 615-620
25. Tarin D. Tumor Metastasis. In: McGee J., Isaacson P.G., and Wright N. (Eds). Principles of Pathology. Oxford Textbook of Pathology vol. 1 (1992), Oxford University Press, Oxford 607-633
26. Tarin D., and Price J.E. Influence of microenvironment and vascular anatomy on "metastatic" colonization potential of mammary tumors. Cancer Res. 41 9 Pt 1 (1981) 3604-3609
27. Tarin D., Price J.E., Kettlewell M.G., Souter R.G., Vass A.C., and Crossley B. Mechanisms of human tumor metastasis studied in patients with peritoneovenous shunts. Cancer Res. 44 8 (1984) 3584-3592
28. Urquidi V., Sloan D., Kawai K., et al. Contrasting expression of thrombospondin-1 and osteopontin correlates with absence or presence of metastatic phenotype in an isogenic model of spontaneous human breast cancer metastasis. Clin. Cancer Res. 8 1 (2002) 61-74
29. van de Vijver M.J., He Y.D., van't Veer L.J., et al. A gene-expression signature as a predictor of survival in breast cancer. N. Engl. J. Med. 347 25 (2002) 1999-2009
30. van't Veer L.J., Dai H., van de Vijver M.J., et al. Gene expression profiling predicts clinical outcome of breast cancer. Nature 415 (2002) 530-536
31. Wang Y., Klijn J.G., Zhang Y., et al. Gene-expression profiles to predict distant metastasis of lymph-node-negative primary breast cancer. Lancet 365 9460 (2005) 671-679
32. Weigelt B., Glas A.M., Wessels L.F., Witteveen A.T., Peterse J.L., and van't Veer L.J. Gene expression profiles of primary breast tumors maintained in distant metastases. Proc. Natl. Acad. Sci. USA 100 26 (2003) 15901-15905
33. Weigelt B., Wessels L.F., Bosma A.J., et al. No common denominator for breast cancer lymph node metastasis. Br. J. Cancer 93 8 (2005) 924-932
34. Weigelt B., Hu Z., He X., et al. Molecular portraits and 70-gene prognosis signature are preserved throughout the metastatic process of breast cancer. Cancer Res. 65 20 (2005) 9155-9158